Quick Answer
Vitamin K Fracture Prevention Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Secondary outcomes included the risk of hip fracture, non-vertebral fracture, vertebral fracture, and falling, as well as the total number of falls.
Key Takeaways
- 01Secondary outcomes included the risk of hip fracture, non-vertebral fracture, vertebral fracture, and falling, as well as the total number of falls. [Massé O (2026)]
- 02Pairs of reviewers independently screened trials, extracted data, and assessed risk of bias using the second version of Cochrane's risk of bias tool. [Massé O (2026)]
- 03Participants in most of the trials were community dwelling (87%) and not at high risk of fractures or falls (73%). [Massé O (2026)]
- 04Objective To assess the effect of calcium, vitamin D, or combined supplementation on fractures and falls in adults. [Massé O (2026)]
The current Migaku evidence database contains 1 reusable source document for Vitamin K Fracture Prevention Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Secondary outcomes included the risk of hip fracture, non-vertebral fracture, vertebral fracture, and falling, as well as the total number of falls. [Massé O (2026); evidence level 1]
- Pairs of reviewers independently screened trials, extracted data, and assessed risk of bias using the second version of Cochrane's risk of bias tool. [Massé O (2026); evidence level 1]
- Participants in most of the trials were community dwelling (87%) and not at high risk of fractures or falls (73%). [Massé O (2026); evidence level 1]
- Objective To assess the effect of calcium, vitamin D, or combined supplementation on fractures and falls in adults. [Massé O (2026); evidence level 1]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources